ArticleGenome biology2026
Comprehensive benchmarking of RNA velocity methods across single-cell datasets.
Article in Genome biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comprehensive benchmarking of RNA velocity methods across single-cell datasets.Genome biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundRNA velocity provides a powerful framework for inferring cellular dynamics from single-cell RNA sequencing data. The rapid proliferation of computational methods within this field has prompted a need for systematic evaluation. However, existing comparisons often suffer from limited scope or incomplete task design, leaving users without clear guidance. Consequently, there is a lack of a comprehensive and standardized benchmark that evaluates methods across diverse biological and technical scenarios using appropriate, context-specific metrics.
resultsIn this study, we present a comprehensive benchmark of 19 computational RNA velocity tools covering 30 distinct methods. We systematically evaluate 25 RNA-only methods across eight evaluation tasks, designating directional consistency, temporal precision, negative control robustness, and sequencing depth stability as core tasks, while assessing five multimodal-enhanced methods specifically on the multimodal integration task. These assessments utilize 34 datasets spanning 26 real-world and eight simulated scenarios. Our results reveal a clear trade-off between directional consistency and negative control robustness, distinct group-wise behaviors across temporal modeling strategies, and variability driven by sequencing depth and quantification choices. This study also identifies several methodological gaps, including the need for improved modeling of gene dependence, more accurate temporal inference strategies, and better-designed multimodal architectures.
conclusionsThis benchmark establishes a unified framework for evaluating RNA velocity methods. Crucially, we provide task-aware guidance to facilitate method selection based on specific biological contexts and technical constraints, rather than relying on a single overall ranking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.